echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > A nationwide survey by the team of researcher Liu Jue from the School of Public Health shows that more than 90% of the research subjects are willing to receive a booster shot of the new crown vaccine

    A nationwide survey by the team of researcher Liu Jue from the School of Public Health shows that more than 90% of the research subjects are willing to receive a booster shot of the new crown vaccine

    • Last Update: 2022-01-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    As of January 9, 2022, the cumulative number of confirmed cases of new coronary pneumonia in the world has exceeded 300 million


    On January 7, 2022, Liu Jue's team published online in "Vaccines" ( Vaccines ) "China's third dose of new crown vaccine acceptance and its influencing factors based on health belief model: a national cross-sectional study " , aiming at To explore the public's willingness to vaccinate the new crown vaccine booster and its influencing factors, in order to provide a scientific reference for promoting the booster vaccination


    According to Liu Jue, the new crown pneumonia (COVID-19) has been raging around the world for nearly two years


    The health belief model is a theoretical model based on needs and motivation theory, cognitive theory and value expectation theory, which is used to focus on people's attitudes and beliefs about health


    In November 2021, Liu Jue's team selected more than 3,000 people from 31 provinces (municipalities and autonomous regions) in China to conduct a survey on their willingness to strengthen vaccination


    Comparison of booster vaccination willingness among different risk perception groups

    Based on the health belief model, the study also found that the higher the perception of susceptibility to new coronary pneumonia, the higher the perception of the severity of new coronary pneumonia, the higher the perception of the benefit of the new crown vaccine booster, and the higher the motivation of booster vaccination, the higher the The higher the willingness to vaccinate


    The multivariate regression results show that the willingness of booster vaccination of those with a history of new crown vaccination is about 5-6 times that of those without a history of vaccination; civil servants have the highest willingness to receive booster vaccination, which is about 5 times that of corporate employees, and self-employed individuals are vaccinated.


    Among the research subjects who were unwilling or uncertain about whether to receive a booster shot, the main reasons for hesitation were that they were not sure about the effect of boosting the defense against the new coronavirus variant, or they believed that two shots of the vaccine were enough to protect themselves, and no booster shot was needed


    Overall, more than 90% of the public in China is willing to receive a booster shot of the COVID-19 vaccine


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.